- Home
- ENGN vs LEO Comparison
ENGN vs LEO Comparison
Compare ENGN & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- LEO
- Stock Information
- Founded
- ENGN 1999
- LEO 1987
- Country
- ENGN Canada
- LEO United States
- Employees
- ENGN N/A
- LEO N/A
- Industry
- ENGN
- LEO Trusts Except Educational Religious and Charitable
- Sector
- ENGN
- LEO Finance
- Exchange
- ENGN Nasdaq
- LEO Nasdaq
- Market Cap
- ENGN 379.3M
- LEO 362.5M
- IPO Year
- ENGN N/A
- LEO N/A
- Fundamental
- Price
- ENGN $8.54
- LEO $6.33
- Analyst Decision
- ENGN Buy
- LEO
- Analyst Count
- ENGN 7
- LEO 0
- Target Price
- ENGN $20.29
- LEO N/A
- AVG Volume (30 Days)
- ENGN 361.4K
- LEO 200.2K
- Earning Date
- ENGN 09-11-2025
- LEO 01-01-0001
- Dividend Yield
- ENGN N/A
- LEO 4.01%
- EPS Growth
- ENGN N/A
- LEO N/A
- EPS
- ENGN N/A
- LEO 0.04
- Revenue
- ENGN N/A
- LEO N/A
- Revenue This Year
- ENGN N/A
- LEO N/A
- Revenue Next Year
- ENGN N/A
- LEO N/A
- P/E Ratio
- ENGN N/A
- LEO $152.00
- Revenue Growth
- ENGN N/A
- LEO N/A
- 52 Week Low
- ENGN $2.65
- LEO $4.98
- 52 Week High
- ENGN $10.35
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- ENGN 60.29
- LEO 64.62
- Support Level
- ENGN $8.49
- LEO $6.20
- Resistance Level
- ENGN $8.85
- LEO $6.33
- Average True Range (ATR)
- ENGN 0.85
- LEO 0.06
- MACD
- ENGN 0.02
- LEO -0.01
- Stochastic Oscillator
- ENGN 63.96
- LEO 81.25
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.